Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Denovicon Therapeutics

Denovicon Therapeutics

Denovicon Therapeutics is a company based in San Diego developing small-molecule therapeutics using software including proprietary AI–molecular modeling algorithm.

Overview

Denovicon Therapeutics is a company based in San Diego developing small-molecule therapeutics using software including proprietary AI–molecular modeling algorithm. They utilize:

  • decades of drug discovery experience,
  • a proven computational platform,
  • state-of-the-art hardware infrastructure,
  • and a proprietary AI–molecular modeling (hybrid) algorithm

to accelerate the development of small-molecule therapeutics. Denovicon Therapeutics aim to reduce the preclinical development timeline of pharmaceutical drug discovery projects from 6 years to 2-3 years.

Founded in 2019 their initial focus is small-molecule therapies for oncology and immuno-oncology targets. The founder and CEO of Denovicon Therapeutics is Scott Bembenek, former computer-aided drug discovery principal scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson.

In January 2020 the company announced a partnership with Scientist.com, an AI-powered pharmaceutical company. The partnership will see the companies combine their proprietary AI procurement and AI molecular modeling platforms to speed up medical research.

Timeline

Patents

Further Resources

Title
Author
Link
Type
Date

References

Golden logo
By using this site, you agree to our Terms & Conditions.